Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,767 | -400,740 | -371,858 | -404,894 | -449,956 |
| Depreciation Amortization | 8,525 | 23,680 | 17,337 | 11,361 | 5,571 |
| Income taxes - deferred | 11,244 | -38,413 | -31,877 | -39,591 | -2,367 |
| Accounts receivable | -5,893 | 14,448 | -5,567 | -4,901 | 42,459 |
| Accounts payable and accrued liabilities | 52,211 | 32,308 | N/A | 407,522 | N/A |
| Other Working Capital | 43,750 | 460,659 | 383,212 | 388,481 | 513,266 |
| Other Operating Activity | -47,077 | -46,172 | 3,468 | -406,125 | -44,863 |
| Operating Cash Flow | $43,993 | $45,770 | $-5,285 | $-48,147 | $64,110 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,500 | 84,885 | 60,122 | 41,820 | -40,825 |
| PPE Investments | -3,855 | -16,983 | -14,210 | -8,953 | -5,133 |
| Purchase Sale Intangibles | -72 | -161 | -117 | -76 | -63 |
| Other Investing Activity | -72 | -161 | -117 | -76 | -63 |
| Investing Cash Flow | $-16,427 | $67,741 | $45,795 | $32,791 | $-46,021 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -18,319 | -24,196 | -3,243 | N/A | N/A |
| Financing Cash Flow | $-18,319 | $-24,196 | $-3,243 | $N/A | $N/A |
| Exchange Rate Effect | 464 | 2,508 | 2,297 | 798 | 601 |
| Beginning Cash Position | 605,177 | 513,354 | 513,354 | 513,354 | 513,354 |
| End Cash Position | 614,888 | 605,177 | 552,918 | 498,796 | 532,044 |
| Net Cash Flow | $9,711 | $91,823 | $39,564 | $-14,558 | $18,690 |
| Free Cash Flow | |||||
| Operating Cash Flow | 43,993 | 45,770 | -5,285 | -48,147 | 64,110 |
| Capital Expenditure | -3,855 | -16,991 | -14,210 | -8,953 | -5,133 |
| Free Cash Flow | 40,138 | 28,779 | -19,495 | -57,100 | 58,977 |